The bill is designed primarily to address the economic damage caused by the COVID-19 pandemic and accelerate the distribution of vaccines and treatments that have proved effective against the pandemic coronavirus. In addition to direct cash payments to millions of U.S. residents, the bill includes nearly $60 billion for vaccine and treatment development, manufacturing, distribution, and tracking, as well as COVID-19 testing and contact tracing. It also includes $11 billion that will go to international groups and foreign governments addressing the pandemic and other public health threats, including $3.5 billion to the Global Fund to Fight AIDS, Tuberculosis and Malaria and $250 million to the President’s Emergency Plan for AIDS Relief, the primary U.S. aid program to address HIV/AIDS.